Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Terbinafine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for terbinafine and what is the scope of terbinafine patent protection?

Terbinafine
is the generic ingredient in three branded drugs marketed by Glaxosmithkline Cons, Novartis, Taro, Breckenridge Pharm, Harris Pharm, Roxane, Wockhardt, Invagen Pharms, Mylan, Cipla Ltd, Glenmark Generics, Orchid Hlthcare, Gedeon Richter Usa, Teva, Dr Reddys Labs Inc, Aurobindo Pharma, and Apotex, and is included in twenty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for terbinafine. One supplier is listed for this compound. There are four tentative approvals for this compound.

Summary for Generic Name: terbinafine

Tradenames:3
Patents:1
Applicants:17
NDAs:24
Drug Master File Entries: see list25
Suppliers / Packagers: see list1
Bulk Api Vendors: see list58
Clinical Trials: see list14
Patent Applications: see list8,346
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:terbinafine at DailyMed

Tentative approvals for TERBINAFINE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 250MG BASETABLET; ORAL
► Subscribe► SubscribeEQ 250MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 250MG BASETABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077136-001Jul 2, 2007DISCNNoNo► Subscribe► Subscribe
Taro
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
CREAM;TOPICAL077511-001Jul 2, 2007OTCNoNo► Subscribe► Subscribe
Novartis
LAMISIL
terbinafine hydrochloride
GRANULE;ORAL022071-002Sep 28, 2007RXYesYes► Subscribe► Subscribe
Glaxosmithkline Cons
LAMISIL
terbinafine hydrochloride
SOLUTION;TOPICAL020749-001Oct 17, 1997DISCNNoNo► Subscribe► Subscribe
Novartis
LAMISIL AT
terbinafine hydrochloride
SPRAY;TOPICAL021124-002Mar 17, 2000OTCYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot